Cargando…
Rigosertib inhibits MEK1–ERK pathway and alleviates lipopolysaccharide‐induced sepsis
BACKGROUND: Here, by using the lipopolysaccharide (LPS)‐induced mice sepsis model, we treated septic wild‐type (WT) mice or MEK1(DD) mice with rigosertib to evaluate its prospective effects on sepsis. METHODS: We also generated macrophages derived from bone marrow from WT or MEK1(DD) mice. These mac...
Autores principales: | Wang, Yin, Du, Pengfei, Jiang, Donghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342218/ https://www.ncbi.nlm.nih.gov/pubmed/34061465 http://dx.doi.org/10.1002/iid3.458 |
Ejemplares similares
-
Rigosertib and Cholangiocarcinoma: A Cell Cycle Affair
por: Malacrida, Alessio, et al.
Publicado: (2021) -
Danshensu alleviates bleomycin-induced pulmonary fibrosis by inhibiting lung fibroblast-to-myofibroblast transition via the MEK/ERK signaling pathway
por: Liu, Huaman, et al.
Publicado: (2021) -
Norcantharidin induces growth inhibition and apoptosis of glioma cells by blocking the Raf/MEK/ERK pathway
por: Zheng, Jie, et al.
Publicado: (2014) -
Pharmaceutical-Grade Rigosertib Is a Microtubule-Destabilizing Agent
por: Jost, Marco, et al.
Publicado: (2020) -
Anti-tumor effects of rigosertib in high-risk neuroblastoma
por: Radke, Katarzyna, et al.
Publicado: (2021)